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Purpose: Neurovascular regulation, including responses to
neural activation that give rise to the blood oxygenation level–
dependent (BOLD) effect, occurs mainly at the arterial and
arteriolar level. The purpose of this study is to develop a
framework for fast imaging of arterial cerebral blood volume
(aCBV) signal suitable for functional imaging studies.
Methods: A variant of the pseudocontinuous arterial spin tag-
ging technique was developed in order to achieve a contrast
that depends on aCBV with little contamination from perfusion
signal by taking advantage of the kinetics of the tag through
the vasculature. This technique tailors the tagging duration
and repetition time for each subject. The proposed technique,
called AVAST, is compared empirically with BOLD imaging and
standard (perfusion-weighted) arterial spin labeling (ASL) tech-
nique, in a motor-visual activation paradigm.
Results: The average Z-scores in the activated area obtained
over all the subjects were 4.25, 5.52, and 7.87 for standard
ASL, AVAST, and BOLD techniques, respectively. The aCBV
contrast obtained from AVAST provided 80% higher average
signal-to-noise ratio and 95% higher average contrast-to-noise
ratio compared with that of the standard ASL measurements.
Conclusion: AVAST exhibits improved activation detection
sensitivity and temporal resolution over the standard ASL
technique, in functional MRI experiments, while preserving its
quantitative nature and statistical advantages. AVAST particu-
larly could be useful in clinical studies of pathological condi-
tions, longitudinal studies of cognitive function, and studies
requiring sustained periods of the condition. Magn Reson
Med 73:1053–1064, 2015. VC 2014 Wiley Periodicals, Inc.
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INTRODUCTION
Cerebral blood volume (CBV) is a very important mea-
surement for the study of a number of neurological disor-
ders that involve vascular dysregulation. These include
hypertension, stroke (1,2), small brain infarcts (3),
Alzheimer disease (4), astrocytoma and other brain
tumors (5,6), and cerebral stenoses (7). The ability to sep-
arate the arterial compartment from the venous compart-
ment of CBV may provide additional information not
obtainable by imaging the total CBV [e.g., in steno-
occlusive disease of the internal carotid artery (8)]. It
may also provide insights into vascular control mecha-
nisms in both healthy and diseased tissue (6,8,9).
Cerebral perfusion is regulated at the arteriolar level.
Thus, measurement of arterial CBV (aCBV) can be an
essential indicator of vascular reactivity (9) and thus can
also be used to study the clinical conditions during
which the normal relation between cerebral blood flow
(CBF), CBV, and blood oxygenation is disrupted. Arterial
and venous vessels show considerably different
responses during neuronal activation (10,11), and thus
imaging of arterial cerebral blood volume (aCBV) can
also provide important information for the study of
human brain function and cognition. Indeed, functional
magnetic resonance imaging (fMRI) using physiological
parameters such as CBF or CBV, unlike BOLD fMRI, pro-
vides a quantifiable contrast and is also more closely
related to neural activity (12–14). These methods can
also be much less sensitive to the local susceptibility
artifacts due to the use of shorter echo times (TEs) or by
employing imaging techniques that are less sensitive to
the field inhomogeneity (e.g., fast spin echo). This would
have specific use in areas of the brain that lie near air
spaces such as frontal and low brain regions, which is
an issue plaguing the BOLD effect (15). Furthermore,
dynamic measurement of aCBV can provide critical
information about the mechanism of the blood oxygen
level–dependent (BOLD) contrast itself (16).
Because of these potential advantages, CBF-, CBV-,
and aCBV-based functional MRI methods have recently
received attention as alternative and complementary
techniques to BOLD fMRI. These methods, however, gen-
erally have been hampered in terms of signal-to-noise
ratio (SNR), temporal resolution, and multislice imaging
capability.
Different methods have been proposed for noninvasive
measurement of aCBV in animals (17) and humans (18–
21). Most prominently, iVASO (21) uses the difference in
T1 relaxation time of blood and tissue to assess the
aCBV. This method, however, is based on a set of
assumptions about the arterial arrival time and T1 val-
ues, which requires further verification (22). Alterna-
tively, aCBV can also be estimated from the signal
obtained from variants of arterial spin labeling (ASL)
techniques. Some techniques obtain ASL images at dif-
ferent postlabeling delays and quantify the aCBV by
modeling the collected signal (18–20). Several other tech-
niques take differencing ASL signals with and without
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flow-crusher gradients in order to isolate the arterial sig-
nal (18,22–24). Another technique, called MOTIVE (17),
uses magnetization transfer along with ASL to modulate
the tissue and blood signals and estimate the aCBV in
animals. Although recent improvements in imaging and
labeling techniques such as three-dimensional (3D)
GRASE readout (25), background suppression (26), and
optimized labeling schemes (27–30) can reduce practical
issues of these techniques, and despite the fact that all of
these methods have been shown to be useful in various
applications, many are still not practical for clinical
studies or cognitive psychology experiments. These
experiments are often more demanding in terms of spa-
tial coverage and resolution as well as temporal resolu-
tion, and hence may not permit long acquisition times or
additional measurements of physiological constants.
The purpose of this study is to develop a simple,
novel, dynamic aCBV measurement technique based on
pseudocontinuous arterial spin labeling (pCASL) (30,31)
that is suitable for functional imaging experiments. We
refer to our proposed measurement technique as arterial
volume using arterial spin tagging (AVAST). AVAST tai-
lors the tagging duration and repetition time (TR) for
each subject to achieve a contrast that depends on aCBV
with little or no contamination from perfusion signal.
AVAST also allows for a fast acquisition rate (TR 2.2
s), making it suitable for dynamic fMRI experiments.
AVAST offers sensitivity to brain activation that is on
par with BOLD imaging and is superior to CBF ASL,
while maintaining many advantages of CBF ASL imaging
such as reduced sensitivity to susceptibility artifact,
improved localization (12), quantifiable signal, and
reduced sensitivity to the MR scanner signal drift (32).
We demonstrate AVAST using numerical simulations
and in vivo experimental data. We then compare it with
standard (CBF) ASL and BOLD techniques in terms of
sensitivity, reproducibility, locus of activation, and tem-
poral response for fMRI experiments.
METHODS
Theory
Our strategy was to design the timing parameters of a
continuous ASL sequence such that the signal was
acquired when the tagged spins were primarily still in
the arteries before they had filled the capillaries.
Through the adjustment of the timing parameters, the
contribution from tagged spins in the capillary and tis-
sue compartments was the same in both the control and
tagged images and therefore could be subtracted out. We
considered a given voxel to consist of three separate
compartments through which blood water flows: the
arterial compartment, the capillary and tissue compart-
ment, and the venous compartment. Here we simply
refer to the combined capillary and extravascular tissue
as “tissue.” In an ASL experiment, the tagged spins
entered the voxel via the arterial compartment and
exchanged through the capillaries/tissue on its way to
the venous compartment, from which it left the voxel. At
3T and below, T1 decay prevented the tagged spins from
retaining their tag by the time they reached the venous
compartment, so it could be safely neglected.
Therefore, for our purposes, the observed ASL signal
can be split into an arterial and a tissue compartment
(SASL 5 Sa 1 St) and modeled separately. Arterial signal
(Sa) in a continuous ASL experiment can be expressed by
adapting the general kinetic model (33) for magnetization
difference between tagged and control images as follows:
SaðtÞ ¼ DMaðtÞ ¼ 2a:Ma0:aCBV :cðtÞ [1]
cðtÞ ¼ rectðt;wÞ  ½kðt  t1Þ:mðtÞ [2]
kðtÞ ¼ S
ð1þSPÞ
Gð1þ SPÞ t
SPeSt
 
[3]
mðtÞ ¼ et=T1a [4]
where Ma0 is the equilibrium magnetization of arterial
blood and Ma(t) describes the magnetization of arterial
blood at time t. aCBV is the aCBV fraction in a given
voxel, a is the inversion efficiency of the ASL pulse, and
rect(t,w) describes a rectangular tagging function of dura-
tion w. The mean time it takes for the tagged spins to
reach the voxel is t1, or the “arterial arrival time.” The
bolus of tagged spins experiences longitudinal relaxa-
tion, as well as dispersion of velocities as it moves up
the arterial network. m(t) represents the longitudinal
magnetization relaxation function defined as the fraction
of original longitudinal magnetization tag carried by the
water molecules that remains at a time t after their
arrival in the voxel and is characterized by a decaying
exponential with time constant T1a (T1 decay of blood in
artery). The dispersion of the tag during travel to the
imaging plane can be approximated by convolving the
input function with a Gamma kernel k(t) (34,35) where S
and P characterize the “sharpness” and the “time-to-
peak” of the kernel.
The arterial tag in turn serves as an input to the tissue
compartment. The tissue signal (St), can be expressed as
a second convolution
StðtÞ ¼ SaðtÞ  f  fe
f
lðtt2Þ  eðtt2ÞT1tg: [5]
Here, the second term in the convolution captures the
fraction, f (perfusion), of tag from the tissue after a short
delay or “tissue transit time,” t2, and the decay of the
tag’s longitudinal magnetization in the tissue compart-
ment with time constant T1t (T1 decay of blood in tis-
sue). l is the blood–brain partition coefficient for water
in the whole brain (36).
Intuitively, this framework describes the process by
which the tag is taken up and washes out of the arterial
compartment and then the tissue compartment of a given
voxel. The goal of the following simulations was to find a
range of pulse sequence timing parameters that produces
an ASL signal that is primarily dominated by the arterial
compartment and to characterize the observed signals.
Simulations
We simulated the general kinetics of the ASL signal at
different TRs and tagging durations using Eqs. [1–5] in
order to explore the effect of the pulse sequence timing
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parameters with respect to multiple arterial arrival and tis-
sue transit times. We assumed that image acquisition hap-
pens instantly after the tagging period (i.e., no
postinversion delays). We used the following constants in
the model [f ¼ 0.015 mL/g/s, M0a ¼ 3000, aCBV ¼ 2 mL/
100 mL, T1a ¼ 1.6 s (37), T1t ¼ 1.4 s (38), a ¼ 0.8 (28), l ¼
0.9 mL/g]. M0a is an arbitrary signal intensity representing
the equilibrium magnetization of arterial blood. To account
for the dispersion of tagged blood, we convolved the input
function with input function with the Gamma kernel pre-
sented in Eq. [3] using the parameters suggested by Chap-
pell et al. (35) (s ¼ 0.38, P ¼ 0.11). Arterial arrival time
(t1) and tissue transit time (t2) were 1 s and 0.5 s (39).
Figure 1 shows a simulation of the ASL signal arising
from the arterial and tissue compartments separately
(recall that the ASL signal consists of the subtraction of
a tagged image from a control image) acquired with sev-
eral different timing parameters. The contribution of
each compartment to the ASL signal depends on the
pulse sequence’s timing parameters along with each sub-
ject’s arterial arrival time, t1, and local arterial delay or
tissue transit time, t2. If the tagging duration is relatively
long (>1 s) and a delay greater than the arterial arrival
time is introduced between the tagging and acquisition
portions of the sequence, the tag clears the arterial com-
partment and fills the tissue compartment. Thus, the arte-
rial contribution to the ASL signal could be eliminated
using a long postinversion delay (Fig. 1a) (40,41). Without
a postinversion delay (Fig. 1b), the ASL signal was a mix-
ture of arterial and tissue signals. Note that changing the
tagging duration and the TR determined the amount of tag
in the arterial and tissue compartments when the control
and tagged images were collected (Fig. 1b–1d). As can be
seen in (Fig. 1c), by choosing the proper TR and tagging
duration, it was possible to have the same contribution
from tissue in the control and tagged images. In this case,
the tissue signal subtracted out in the ASL signal, and the
remaining observed signal arose from the arterial compart-
ment alone, which was our goal for this technique.
We used this framework to compute the contributions of
the arterial and tissue compartments to the ASL signal as a
function of tagging duration. Thus, we were able to identify
a range of tagging durations for which the net signal was
mostly arterial with small tissue contribution to the signal.
FIG. 1. Simulated kinetics of the concentration of label in the tissue arising from arterial and tissue compartments in a given voxel using
different timing parameters. The tagging function, arterial and tissue signals, and total ASL signal time courses are shown using green,
red, blue, and black curves, respectively. The timing of the acquisition of the first pair of control and tagged images is shown using dot-
ted vertical lines. The individual contributions of tissue and arterial compartments in the subtraction of tagged from control image are
also indicated on the right side of each curve by blue and red arrows, respectively. a: Standard continuous ASL experiment employing
a long postinversion delay (large tissue signal, no arterial signal) yielding perfusion-weighted images. b: Continuous ASL experiment
without postinversion delay (small tissue signal, large arterial signal. c: Continuous ASL experiment without postinversion delay and with
optimal tagging duration for aCBV measurement (no tissue signal, large arterial signal). d: Continuous ASL experiment without postinver-
sion delay and with shorter than optimal tagging duration for aCBV measurement (small negative tissue signal, large arterial signal).
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The contribution of the arterial and tissue compart-
ments to the ASL signal as a function of tagging duration
is shown in Fig. 2, assuming that the image acquisition
happened at the end of the tagging period. The high-
lighted points (red crosses) on the black curve in Fig. 2
correspond to the timing parameters shown in Fig. 1b–
1d. As can be seen in Fig. 2, there are several tagging
durations for which the tissue contribution to the arterial
signal is zero. At these “zero-crossings” of the tissue con-
tribution curve (blue), there is still 50%–75% of arte-
rial contribution to the ASL signal. Among these points,
the location indicated in Fig. 2 by a red rectangle sug-
gests a very stable range of tagging times for which the
net signal is mostly arterial (i.e., the tissue contribution
to the signal is <5%). Consequently, using this tagging
duration, the fractional ASL signal change upon activa-
tion during a functional study is related to the local
changes in the arterial blood volume. We refer to this
timing combination as the “aCBV point” and use it to
collect aCBV-weighted images.
In practical terms, the first task in the AVAST tech-
nique is to identify the timing parameters of the aCBV
point by testing a range of tagging durations with flow
suppression gradients, in order to isolate the contribu-
tion of the tissue signal. Once the aCBV point is identi-
fied in a preliminary scan, a time series of dynamic
aCBV images can be collected by fixing the pulse
sequence parameters to those of the aCBV point and
turning off the flow suppression gradients.
Sensitivity to Timing Variations
The location of the aCBV point is determined by the sub-
ject’s specific arterial arrival and tissue transit times rela-
tive to the image acquisition parameters. Therefore, the
best selection of parameters will vary from subject to sub-
ject and over brain regions. To evaluate the sensitivity of
AVAST to these timing variations, we conducted a simu-
lation study. We simulated the ASL signal for a case in
which the aCBV sequence was calibrated for a specific
region with a given set of physiological parameters [arte-
rial arrival time of 1 s and tissue transit time of 0.5 s (39)].
Keeping the acquisition parameters the same, in Fig. 3a
and 3b, we calculated what happens to the signals when
the voxels’ arterial arrival and tissue transit times differed
up to 0.5 s from the original calibration in order to illus-
trate the amount of tissue contamination that can be
potentially found using this method. As shown in Fig. 3a
FIG. 2. Simulated ASL signal (control minus tagged images) as a
function of tagging duration considering no postinversion delay.
Arterial arrival time assumed to be 1 s. TR was adjusted dynami-
cally to accommodate the increasing tagging duration. Points
highlighted with red x’s correspond to the kinetic curves shown in
Fig. 1b, 1c, and 1d.
FIG. 3. Simulation study of the sensitivity of AVAST to the arterial arrival time and tissue transit time variability across different areas of
the brain or under different conditions (e.g., activation). aCBV acquisition was optimized for a voxel where the arterial arrival time (t1)
and the tissue transit time (t2) are 1 and 0.5 (s), respectively. The individual contributions of arterial and tissue compartments in the ASL
subtraction signal (control minus tagged images) were calculated for a broad range of transit times, different (60.5 s) from the ones
used in the aCBV optimization. Plots show total (arterial þ tissue) and tissue signals. Subplot (a) indicates the effect of variation in arte-
rial arrival time. Subplot (b) indicates the effect of variation in tissue transit time. Simulated change in the AVAST signal between rest
and activation resulting from the reduction in the tissue transit time in response to neural activation is also shown in subplot (c).
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and 3b, if we were wrong by 50% in the arterial arrival
time or tissue transit time, the contribution from the
tissue-tagged spins to the aCBV signal was 10 %.
In addition to spatial variability, tissue transit time
also changes during the neuronal activation. It has been
shown that neuronal activation is accompanied by a
local reduction in tissue transit time of 0.150 6 0.045 s
(42). As a result of this reduction, there will be a change
in the total signal between rest and activation condi-
tions. Figure 3c shows the relative change in the total
signal between rest and activation as a function of the
reduction in the tissue transit time during neuronal acti-
vation. Since the vasodilation happens locally at the area
of activation, in this simulation we assumed that the
neuronal activation mainly affects the tissue transit time
and not the arterial arrival time. It is important to note
that this change is due to the shift in the aCBV point
and not due to the actual change in aCBV due to activa-
tion. It can be seen that there could be as much as a
10% increase in the signal because of the activation-
induced reduction in the transit time.
Quantification
Using Eqs. [1–4], it is possible to quantify the aCBV sig-
nal obtained using AVAST. To this end, it is necessary
to estimate the arterial arrival time from the tagging
plane at the neck to the imaging plane. We estimated the
arterial arrival time by varying the tagging duration and
TR and following the changes in the ASL signal without
using flow crusher gradients (42,43). The signal can then
be quantified using the following equations:
aCBV ¼ DMðTRÞ
2a:Ma0  cðTRÞ [6]
Ma0 ¼ MaðTRÞðsin u  eTR=T1aÞ [7]
in which u is the flip angle of 3D imaging pulse and Ma
is the equilibrium magnetization of the arterial blood in
the sagittal sinus measured from the mean of the control
images.
In Vivo Experiments
3D Image Acquisition
We employed a 3D imaging pulse sequence with multi-
shot (segmented) readouts for imaging the aCBV signal.
The readout is a 3D stack of spiral trajectories imple-
mented using radiofrequency spoiling . Besides a modest
increase in SNR relative to two-dimensional acquisition
(44), the 3D acquisition ensures the same acquisition
delay for the entire imaging volume relative to the tag-
ging period and therefore provides us with the capability
to measure the aCBV in a volume rather than a single
slice (44). If we were to use sequential two-dimensional
imaging, each slice would be acquired at a different post-
inversion delay and consequently, the optimality of the
aCBV acquisition would be slice-dependent.
The 3D gradient echo spiral images in this study were
obtained using the following parameters: pulse TE ¼
0.004 s; field of view ¼ 24 cm; slab thickness ¼ 11 cm;
and matrix size ¼ 64  64  22. Planes along the kz-
dimension were sampled starting at the center of k-space
and moving outward alternating between negative and
positive kz increments using 22 excitations, each taking
0.023 s. We used a cubic flip-angle schedule from 15 to
90 degrees as we traversed k-space along the slab-select
direction, in order to reduce blurring along the slice-
encoding dimension (44). Due to use of a low flip angle
we did not consider spin history effects and assumed
those to be negligible. The TR and tagging durations
used for each set of experiments are explained in the
subsequent sections.
aCBV calibration
Our simulations suggest that the timing parameters pro-
ducing the aCBV images is determined by each subject’s
specific arterial arrival and tissue transit times relative to
the image acquisition parameters. Therefore, the best
selection of parameters varied from subject to subject,
although our simulations indicate that the technique is
not very sensitive to errors in transit times. For each sub-
ject, we identified the timing parameters of the aCBV
point by running a calibration sequence before the func-
tional experiment, as follows. The calibration sequence
tests the ASL signal over a range of TRs in the presence
of flow suppression gradients (similar to the blue curve
in Fig. 2). Arterial signals were suppressed by using a
pair of bipolar crusher gradients (b ¼ 4 s/mm2) along the
Z-direction providing a cut off velocity of 1cm/s. Guided
by the simulation result and by previous experience
(42,43,45), TR was varied from 1.5 to 2.5 s, steps of 0.1 s,
while keeping the tagging duration 0.5 s shorter than TR
to allow the acquisition of 22 slices using for the calibra-
tion sequence. For each TR, we collected eight tag/con-
trol images and averaged them together during
postprocessing. The total scan time for the aCBV calibra-
tion using these parameters was 352 s.
The images were reconstructed, pairwise subtracted,
and averaged for each TR. The TR and tagging duration
yielding the lowest ASL signal in the presence of flow
crusher gradients was selected as optimal for aCBV (i.e.,
aCBV point highlighted with a red box in Fig. 2).
Functional Experiments
Using the obtained aCBV parameters, we performed a
functional aCBV experiment and compared it with the
result of functional CBF and BOLD experiments. Ten
subjects were scanned using a 3.0 T Signa Excite scanner
(General Electric, Waukesha, Wisconsin, USA). We
employed pseudocontinuous tagging pulses (30,31) for
functional CBF and aCBV experiments. The tagging effi-
ciency of the pCASL pulse sequence was optimized by
correcting for the field off-resonance (28). Image acquisi-
tion was performed employing the above-mentioned seg-
mented 3D spiral acquisition pulse.
Subjects performed a simultaneous motor (sequential
finger opposition) and visual (8-Hz flashing checker-
board) activation task while being scanned using BOLD-
weighted imaging, perfusion-weighted ASL, and AVAST,
as described below. The activation paradigm consisted of
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five cycles of alternating rest (30 s) and activation (30 s).
Total functional scan time for all methods was 300 s.
The first activation map was obtained using the func-
tional aCBV scheme of AVAST (i.e., TR/tagging duration
obtained from the calibration scan, no postinversion
delay). The second map was obtained using a functional
CBF scheme employing a standard ASL technique (TR ¼
4 s; tagging duration ¼ 2 s; postinversion delay ¼ 1.5 s).
A BOLD fMRI study was also conducted (single-shot gra-
dient echo reverse spiral pulse sequence (46): TE ¼ 0.03
s; TR ¼ 2 s; flip angle ¼ 90; same field of view; slice
location and resolution as aCBV and CBF experiments)
for comparison purposes. Four dummy scans were col-
lected in the beginning of all functional scans to make
sure that steady state was reached. To compare the
reproducibility of each method, we repeated the func-
tional experiments on the same day, using each method
for all subjects. All datasets were reconstructed, sur-
round subtracted, and analyzed by estimation of stand-
ard general linear model using the custom-written
software FASL01 (http://fmri.research.umich.edu/resour-
ces/software/shared_code.php).
SNR and CNR Calculations
We characterized our functional experiment by a linear
model as described by Mumford and Nichols (47) and
Hernandez-Garcia et al. (48):
yt ¼ b0 þ b1x1t þ Et [8]
for each time point t 5 1,. . ., n. The first regressor and
its coefficient parameter, b0, indicate the baseline signal
for the BOLD experiment and baseline subtraction ASL
signal for the aCBV and CBF experiments. The second
regressor x1t with its regression coefficient, b1, describes
the signal (BOLD or subtraction ASL signal) difference
due to activation and thus the amplitude of b1 is indica-
tive of contrast of the signal between rest and activation.
The square root of the estimated variance of the effects
of interest (sb0and sb1 ) also corresponds to noise. There-
fore, the temporal SNR and CNR of the functional experi-
ment conducted using each method can be calculated
using:
SNR ¼ Mean
v2Vbrn
b0v
sb0v
 
[9]
And
CNR ¼ Mean
v2Vact
b1v
sb0v
 
[10]
in which Vbrn and Vact, respectively, represent total brain
voxels and activated brain voxels in each experiment.
RESULTS
aCBV Calibration
Figure 4 shows the ASL signal acquired at different TRs
over a wide range of tagging durations (0.6–3 s) with and
without the flow crusher gradients in a region of interest
containing 50 voxels of gray matter around the motor
cortex area from one of the subjects. The black curve cor-
responds to the ASL signal without the flow crusher gra-
dients and contains both arterial and tissue signals. The
blue curve corresponds to the ASL signal with the flow
crusher gradients, therefore it arises from the tissue signal
(CBF). The tissue curve was used to estimate the optimal
aCBV parameters by finding the aCBV point (pointed to by
the red arrow). In agreement with our simulations (see
Fig. 2), by incrementing the tagging duration and TR
together, we were able to isolate the arterial contribution
to the ASL signal. Note the temporal shift of the tissue-
only ASL signals relative to the whole signals (arterial
plus tissue). This is to be expected, since these spins must
traverse the branching arteries and arterioles before they
reach the capillary bed, where they can exchange. This
delay corresponds to tissue transit time in our model. The
range of TRs for the aCBV point estimated for our subjects
was 2.0–2.5 s (mean/standard deviation ¼ 2.26/1.8 s).
Also note that, in practice, only the tissue curve over a
narrower range of tagging durations (1.5–2.5 s) is necessary
to conduct an AVAST experiment.
Functional Study Results
All experiments produced activation in visual cortex,
motor cortex and supplementary motor area using a Z-
threshold of 5 (Z > 5). Figure 5 shows the activation
maps from a representative subject obtained using stand-
ard ASL, AVAST, and BOLD fMRI overlaid on the corre-
sponding average image. To help compare the activated
areas structurally, they are also shown together on a sep-
arate image, with the overlapping areas highlighted in
yellow. A 3D visualization of the activated areas is also
presented. Active areas in the AVAST map were more
focal (less scattered) than BOLD in all subjects. AVAST
also produced wider activated areas compared with
standard ASL.
FIG. 4. Mean ASL signal measured for different tagging durations
with (blue) and without (black) flow crusher gradients. For each
measurement, TR was also adjusted to accommodate the increas-
ing tagging duration. Error bars indicate standard deviation.
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We compared the hemodynamic response of these
methods by averaging the time course of the top 1% of
voxels with the highest Z-score for each technique across
the five cycles and subjects (n ¼ 10). It is important to
note that each method measures different physiological
parameters and therefore the locus of the activation area
detected using each method is different. Thus, to com-
pare the CBF, aCBV, and BOLD time courses, it was not
possible to choose an anatomical region of interest that
fairly represented the activated area for all three meth-
ods. Moreover, since these methods have quite different
sensitivities, comparing the results by choosing a fixed
Z-threshold leads to a different number of voxels for
comparison and will not be statistically equivalent for
all methods. Therefore, we compared the most signifi-
cant voxels of each method by choosing the voxels with
the top 1% Z-scores for each method. Additionally,
because the TR for AVAST experiments is not the same
for different subjects, all aCBV time courses were first
linearly interpolated to TR ¼ 2 s before averaging.
FIG. 5. Orthogonal slices illustrating activation maps (Z>5) and their corresponding signal time course for a single representative subject
obtained using (a) BOLD, (b) standard ASL (CBF contrast), and (c) AVAST (aCBV contrast) during visual and unilateral motor stimulation.
Each activation map is overlaid on the average image corresponding to the technique used to generate that map. Time courses are
averaged over the overlapping activated voxels for each technique. Error bars indicate the standard deviation across these voxels. Dark
lines under the time courses show periods of stimulation. (d) The activated areas detected using each technique are shown in green
(BOLD), red (standard ASL), and blue (AVAST). Overlapping voxels are shown in yellow. A 3D visualization of the activated areas also
presented.
FIG. 6. Hemodynamic response averaged across five cycles of
stimulation over all subjects (n ¼ 10) for aCBV, CBF and BOLD
fMRI techniques. Error bars indicate the standard deviation across
subjects. Dark lines show the period of stimulation.
Arterial Cerebral Blood Volume–Weighted Functional MRI 1059
Figure 6 shows the comparison of the hemodynamic
response obtained using BOLD, standard ASL (CBF-
weighted contrast), and AVAST (aCBV-weighted con-
trast) methods. It can be seen that the CBF and BOLD
responses have a delayed time to peak and slower return
to baseline than aCBV. Poststimuli undershoot in the
aCBV time courses was observed, but it returned to base-
line faster than the BOLD signal. The average percentage
signal changes during activation for BOLD, aCBV, and
CBF signals were 2.4%, 85%, and 46%, respectively.
To compare the sensitivity of each method, we used
two approaches: 1) we compared the mean of the top
1% Z-scores (Fig. 7a); 2) we compared the mean Z-
score within the overlapping activated areas defined as
the voxels with Z>2 for all three methods (Fig. 7b). Fig-
ure 7 shows the calculated mean Z-scores for all 10
subjects. Average Z-scores calculated using the first
approach for all the subjects were 4.25, 5.52, and 7.87
for standard ASL, AVAST, and BOLD, respectively.
These numbers were 3.54, 4.21, and 5.42 using the sec-
ond approach. These results indicate the superior acti-
vation detection sensitivity of AVAST compared with
standard ASL.
In order to understand the spatial relationship between
activation maps obtained with these methods in terms of
locus of activation, we examined the overlap of the top
1% of the activated voxels between AVAST-BOLD, ASL-
AVAST, and ASL-BOLD. Figure 8a shows the calculated
number of overlapping voxels for all 10 subjects. The
average overlaps over all subjects were 54%, 36%, and
46%, respectively, which was expected considering the
different physiological origin of each signal. In order to
compare the reproducibility of each technique, we also
calculated the overlap of the top 1% of the activated
voxels between two runs for each method (Fig. 8b). The
results indicate that AVAST has superior reproducibility
compared with standard ASL but is still outperformed
by BOLD.
The CNR and SNR of each method were calculated
using Eqs. [9] and [10] and were averaged over all sub-
jects (Table 1). It is important to note that the total scan
time is the same for all techniques. However, since these
techniques have different TRs, the number of measure-
ments is not the same for these measurements. To
account for the differences in TR, we also calculated
SNR and CNR of a single measurement for the techni-
ques. Our calculations indicate that AVAST outper-
formed the standard ASL in terms of CNR and SNR, both
in single measurement and the whole scan. Due to sig-
nificantly better temporal resolution of AVAST
FIG. 7. Boxplots of mean Z-
score values averaged over (a)
the top 1% of voxels and (b)
overlapping activated voxels
(Z>2) for BOLD, AVAST, and
standard ASL techniques across
all subjects.
FIG. 8. Number of overlapping activated voxels detected using the AVAST, standard ASL, and BOLD methods (a) between two runs of
different methods and (b) between two runs of the same method.
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compared with ASL, this difference is more pronounced
in the whole scan. BOLD, however, provides the best
CNR and SNR among all techniques. Note that the sub-
traction of control and tag images in AVAST and ASL
experiments led to much smaller signal values compared
with BOLD signals that caused a significant lower SNR
for AVAST and ASL.
aCBV Quantification
Figure 9a shows an example of aCBV maps estimated in
the resting state using AVAST. The aCBV values over
the brain had a mean 6 standard deviation of 1.1 6 1
mL/100 mL. Figure 9b shows the histogram of the
obtained values in gray matter. The large spread in gray
matter aCBV values is likely related to different partial
volume effects with vessels, white matter, and cerebro-
spinal fluid.
DISCUSSION
Inspecting both simulated and experimental kinetic
curves (Fig. 2), one may notice that there are two other
zero crossing points (0.7 and 1.1 s in Fig. 2) that can
potentially be used for obtaining an aCBV-weighted sig-
nal. Although shorter TRs of these two points are desira-
ble, rapid changes in total ASL around these two points
would make them sensitive to transit timing variations.
For that reason, the third point was used in this study.
In this regime, the transit time variations led to only a
small contamination from the tissue signal, since the rate
of change in the ASL signal with respect to transit time
is much slower.
To attain an aCBV-weighted signal with minimum
contribution from the BOLD effect, the shortest TE possi-
ble is used in AVAST. While at the TE of choice in our
experiment the sensitivity of the BOLD signal is approxi-
mately <10% of that of the typical BOLD experiments
(49), it may still contribute to the error of the measure-
ment. If this contribution is severe, one can include the
expected BOLD response in the general linear model as a
nuisance regressor, as in (11,50), and eliminate any pos-
sible BOLD contribution from the analysis. In this study,
however, we have chosen to keep preprocessing to a
minimum in order to show a fair comparison among
techniques.
The model for ASL signal used in this study is a well-
established model that frequently has been used and
tested in the literature (33). Although more complicated
models for ASL signal have been proposed in the litera-
ture (35,43,51), the consistency of our experimental
results with the simulation results indicate that the com-
plexity of the model we used for our simulation is
appropriate for this application.
AVAST requires a calibration scan before the fMRI
scan. Once the aCBV parameters are found, however,
AVAST does not require multiple measurements during
the actual fMRI experiment, which is a critical advantage
of this method for fMRI applications compared with
other ASL-based techniques proposed for aCBV estima-
tion (18–20,22–24). One drawback of estimating the
aCBV point by finding the zero-crossing point is the
lower SNR of measurements around the zero-crossing
points. We circumvented this problem by averaging eight
tag/control images for each TR. Another solution could
be to collect a larger range of TRs on the calibration
Table 1
Estimated SNR and CNR Averaged Over All Subjects for Each
Method
AVAST
Standard
ASL BOLD
CNR in activated area 1.7 0.9 3.2
SNR in whole brain 12.9 6.6 1594
CNR of single measurement 0.026 0.024 0.021
SNR of single measurement 0.195 0.178 10.626
For AVAST and standard ASL, one pair of tagged and control
images was considered a single measurement.
FIG. 9. Representative aCBV map estimated using (a) AVAST and (b) its corresponding histogram of the estimated aCBV values in gray
matter.
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curve and estimating the aCBV point from a fit of the
above kinetic model.
A new variant of VASO (52) dubbed iVASO has been
proposed recently in order to isolate the arterial compo-
nent of CBV (21). By inverting the spins in a region out-
side the volume of interest and collecting the images at
the time that the arterial blood’s magnetization is at its
null point, iVASO limits the blood nulling to the incom-
ing blood spins, which leads to an increase in SNR and
CNR compared with VASO. AVAST and iVASO pulse
sequences are very similar in terms of tagging the inflow-
ing blood. The differences are that AVAST uses continu-
ous tagging, whereas iVASO uses a pulsed tagging
scheme. Most importantly, the contrast in iVASO is
based on the nulling of arterial blood, whereas AVAST
measures the amount of label in the arteries. However,
the use of iVASO in its current implementation faces a
number of challenges for fMRI applications, including
slice coverage, cerebrospinal fluid contamination, and
spatial variations in inversion efficiency and tissue/
blood T1. Some of these issues have been solved in
recent improvements of the VASO technique (53) and
can potentially be implemented for iVASO as well. Hav-
ing said that, AVAST does not face these problems.
Because AVAST tailors the aCBV parameters for each
subject, it is potentially more reliable compared with
iVASO. However, a thorough, empirical, side-by-side
comparison is required to assess the advantages and dis-
advantages of these two methods fairly (though this com-
parison is beyond the scope of the present study).
There is great variability in the literature regarding the
relative aCBV change arising from cerebral activation.
Yan et al. (20) reported a 67.2% and 49.7% aCBV signal
change using the FAIR and QUIPSS II techniques,
respectively. Brookes et al. (19) reported a 33% change
in aCBV signal measured using LL-EPI-STAR technique.
The range of values reported by Hua et al. using iVASO
technique was 58 6 7% (21). Lee et al. (10) reported a
79% change in the aCBV signal. While these results are
lower than the numbers we report in this study (85%),
they are within error of our results. Having said that,
these discrepancies can be mostly explained by the
transit time effects discussed earlier and, to a lesser
degree, by different contributions from the capillary sig-
nals in each method. Differences in spatial resolution,
species, presence or absence of anesthesia, stimulation
paradigm, and age could also contribute to the discrep-
ancy between our observations and previous works.
It should be noted that in both the present study as
well as the mentioned previous works, the relative CBF
and aCBV signal changes are different than resting state
CBF-CBV coupling. This is to be expected, because arte-
rial and venous vessels have been shown to have consid-
erably different responses during neuronal activation
and vascular challenges (e.g., hypercapnia challenge)
(10,54).
Although it has been shown that activation sites
detected using aCBV-weighted signals are in general
more localized in cortical layers (12), the spatial resolu-
tion of our study does not allow for investigating the
exact location of the activation sites with respect to corti-
cal layers and confirm this hypothesis.
The challenges to AVAST, as currently implemented,
are its reduced slice coverage (compared with BOLD)
and the need to acquire a resting-state calibration curve
to determine the optimal sequence timing parameters. In
addition, reduction in the local transit time can muddle
quantification of aCBV signals during activation periods
because it exaggerates the observed signal change as the
result of less T1 decay. For example, if the total transit
time is reduced from 1500 to 1300 ms without an
increase in aCBV, the observed signal will be 10%
greater. While this is detrimental for the quantification
process, it benefits the statistical power of detecting
active regions. This effect is similar to our previous
observations in measuring CBF using Turbo-CASL tech-
nique (43). This effect introduces the need for a correc-
tion scheme for the overestimation of aCBV signal
change during activation. One possible solution for this
problem could be an approach similar to that used by
Hernandez-Garcia et al. (43). Considering these facts, the
application of AVAST at this current stage is confined to
quantification of aCBV at rest, and detecting activation-
induced aCBV changes qualitatively.
The reduction in the arterial arrival time during neural
activation is also accompanied by an increase (10%–
20%) in the local mean blood velocity. If this local
change were to lead to a considerable change in carotid
arteries at the tagging plane, it would cause a reduction
in the tagging efficiency of the pCASL technique (55). In
that case, this reduction in the tagging efficiency needs
to be taken into account for quantification of the results.
However, since the vasodilation happens locally at the
area of activation, it is very unlikely that the neural acti-
vation would cause any detectable change in the blood
velocity at the tagging plane. Also notable is that the tag-
ging efficiency term in the model is multiplicative,
meaning that changes in the efficiency would affect the
amplitude of the curve, but would not shift the aCBV
point.
It should also be noted that we employed a 3D stack of
spirals acquisition scheme in order to eliminate differen-
ces in sensitivity to transit times across slices. Although
it is a multishot sequence (since it applies the shots
along the Kz direction), it does not lead to a slice-timing
shift. Instead, it produces minor blurring along the z-axis
due to T1 effects and also due to inflow spins. We mini-
mized the blurring effects by employing a cubic flip-
angle schedule from 15 to 90, as demonstrated by Niel-
sen and Hernandez-Garcia (44).
CONCLUSION
We have presented a new method called AVAST that
uses a pseudocontinuous labeling scheme to provide an
aCBV-weighted signal suitable for functional imaging
experiments. Our initial results suggest that AVAST pro-
vides superior activation detection sensitivity and tem-
poral resolution over the standard perfusion-weighted
functional ASL methods, closer to those of the BOLD
technique, while retaining the more desirable properties
of ASL techniques. Namely, it yields a readily quantifi-
able physiological parameter, and because it is a subtrac-
tion technique, its noise is mostly white and not
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autoregressive. Furthermore, minimal echo times can be
employed in this scheme, resulting in images that are
less sensitive to susceptibility artifacts compared with
BOLD-weighted imaging. AVAST can be particularly
useful in longitudinal studies of cognitive function and
studies requiring sustained periods of the condition or
state of interest. This technique can also have a central
role in the study of areas of the brain that lie near air
spaces such as frontal and low brain regions which is
quite challenging using BOLD effect. The proposed
method can also be helpful in study of the pathological
conditions during which the normal relation between
CBF, CBV and blood oxygenation is not valid.
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